跳至主要内容
临床试验/EUCTR2006-004447-35-GB
EUCTR2006-004447-35-GB进行中(未招募)1 期

Biological Variation of Insulin Resistance, Testosterone and Cardiovascular Risk Factors In Women with Polycystic Ovarian Syndrome: modification with Rimonabant compared to Metformin. - Rimonabant and Metformin in PCOS

Hull and East Yorkshire Hospital Trust0 个研究点目标入组 56 人开始时间: 2006年9月18日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Polycystic ovarian syndrome
  • BMI greater than 30
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patient should not be currently taking any medications
  • Unwilling for GP to be informed
  • Diabetic patients
  • Uncompensated hypothyroidism
  • Patients not on barrier contraception

研究者

发起方
Hull and East Yorkshire Hospital Trust

相似试验